These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4108884)

  • 41. Clinical experience with thiocarlide (Isoxyl).
    Urbancik B
    Antibiot Chemother; 1970; 16():117-23. PubMed ID: 5535608
    [No Abstract]   [Full Text] [Related]  

  • 42. The activity of thiacetazone, thiambutosine, thiocarlide and sulphamethoxypyridazine against Mycobacterium leprae in mice.
    Colston MJ; Hilson GR; Ellard GA; Gammon PT
    Lepr Rev; 1978 Jun; 49(2):101-13. PubMed ID: 78428
    [No Abstract]   [Full Text] [Related]  

  • 43. [Studies on thiacetazone resistance of tubercle bacilli. I. Thiacetazone sensitivity of tubercle bacilli isolated from previously untreated tuberculous children].
    Osato T; Tsukagoshi K; Shimizu H
    Kekkaku; 1971 May; 46(3):65-70. PubMed ID: 4101569
    [No Abstract]   [Full Text] [Related]  

  • 44. [Influence of antitubercular agents on the endogenous metabolism of mycobacteria].
    Iwainsky H; Reutgen H
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):227-31. PubMed ID: 4973007
    [No Abstract]   [Full Text] [Related]  

  • 45. Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis.
    Belardinelli JM; Morbidoni HR
    Expert Rev Anti Infect Ther; 2013 Apr; 11(4):429-40. PubMed ID: 23566152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on thiacetazone resistance of tubercle bacilli. 3. Cross resistance between thiacetazone and ethionamide].
    Osato T; Tsukagoshi K; Shimizu H
    Kekkaku; 1971 Apr; 46(4):89-92. PubMed ID: 4102105
    [No Abstract]   [Full Text] [Related]  

  • 47. [Activity of Isoxyl on Mycobacterium kansasii; studies in vitro and in the pneumoconiotic guinea pig].
    Tacquet A; Devulder B; Tison F; Martin JC
    Antibiot Chemother; 1970; 16():160-76. PubMed ID: 5535612
    [No Abstract]   [Full Text] [Related]  

  • 48. The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone.
    Gopal P; Dick T
    Int J Antimicrob Agents; 2015 Apr; 45(4):430-3. PubMed ID: 25704063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Simultaneous determination of double labelled isoxyl (3H and 35S) blood levels in man, by radio- and bio-assays].
    Lambelin G; Roncucci R; Simon MJ; Gautier M; Vincze A; Verbist L
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(3):161-72. PubMed ID: 4974984
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isoxyl particles for pulmonary delivery: In vitro cytotoxicity and potency.
    Wang C; Hickey AJ
    Int J Pharm; 2010 Aug; 396(1-2):99-104. PubMed ID: 20600722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Response to the short-course chemotherapy in patients presenting initial resistance].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375
    [No Abstract]   [Full Text] [Related]  

  • 53. Characteristics of African M. tuberculosis.
    Zykov MP; Patel RI
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):70-83. PubMed ID: 4097678
    [No Abstract]   [Full Text] [Related]  

  • 54. Some correlations between chemical structure and mode of action of tuberculostatica. Researches on capreomycin and isoxyl.
    Păunescu E; Stoinescu M; Zaharescu C; Drăguşanu E
    Antibiot Chemother; 1970; 16():10-6. PubMed ID: 4108883
    [No Abstract]   [Full Text] [Related]  

  • 55. [Action of protionamide on tuberculosis mycobacteria in vitro].
    Kalabukha AV; Klimenko MT
    Mikrobiol Zh; 1972; 34(6):778-82. PubMed ID: 4199956
    [No Abstract]   [Full Text] [Related]  

  • 56. [On the adequacy of various solid and liquid culture media for the determination of resistance to isoxyl].
    Meissner G
    Beitr Klin Erforsch Tuberk Lungenkr; 1965 Dec; 131(3):203-20. PubMed ID: 5894126
    [No Abstract]   [Full Text] [Related]  

  • 57. The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1087-9. PubMed ID: 806991
    [No Abstract]   [Full Text] [Related]  

  • 58. [Newest tuberculostatics; importance and feasibility of evaluation in a test tube].
    Trnka L; Havel A; Urbancik R
    Chemotherapy; 1966; 11(2):121-34. PubMed ID: 4959376
    [No Abstract]   [Full Text] [Related]  

  • 59. The determination of resistance of M. tuberculosis to capreomycin.
    Schröder KH; Hensel I
    Antibiot Chemother; 1970; 16():69-72. PubMed ID: 4108899
    [No Abstract]   [Full Text] [Related]  

  • 60. The activity of thiacetazone, thiambutosine and thiocarlide in the chemotherapy of experimental leprosy.
    Colston MJ; Hilson GR
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):123. PubMed ID: 58847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.